Ethics approval and consent to participate
RENAL
Subjects in this study are the first 101 patients enrolled to TRACERx Renal, approved as a prospective cohort study by the National Health Service Research Ethics Committee (11/LO/1996). The study sponsor is the Royal Marsden NHS Foundation Trust.